Compounds > 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole
Page last updated: 2024-11-05

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Carotid Arteriopathies, Traumatic

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Carotid Arteriopathies, Traumatic in 2 studies

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Keswani, AN1
Peyton, KJ2
Durante, W2
Schafer, AI2
Tulis, DA2
Chapman, GB1
Evans, AJ1

Other Studies

2 other studies available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Carotid Arteriopathies, Traumatic

ArticleYear
The cyclic GMP modulators YC-1 and zaprinast reduce vessel remodeling through antiproliferative and proapoptotic effects.
    Journal of cardiovascular pharmacology and therapeutics, 2009, Volume: 14, Issue:2

    Topics: Animals; Apoptosis; Carotid Artery Injuries; Cell Proliferation; Cyclic GMP; Disease Models, Animal;

2009
YC-1, a benzyl indazole derivative, stimulates vascular cGMP and inhibits neointima formation.
    Biochemical and biophysical research communications, 2000, Dec-20, Volume: 279, Issue:2

    Topics: Angioplasty, Balloon; Animals; Carotid Arteries; Carotid Artery Injuries; Carotid Stenosis; Cyclic G

2000